相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Recent Developments in HLA B27 Anterior Uveitis
Denis Wakefield et al.
FRONTIERS IN IMMUNOLOGY (2021)
Correlation of patient preferences to treatment outcomes in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors in Greece
Prodromos Sidiropoulos et al.
CLINICAL RHEUMATOLOGY (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Golimumab improves patient-reported outcomes in daily practice of inflammatory rheumatic diseases in Germany
Klaus Krueger et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D. Reveille et al.
JOURNAL OF RHEUMATOLOGY (2019)
Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort
Pascal Claudepierre et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
Karin Luttropp et al.
BMJ OPEN (2019)
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M. Ward et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
Maria V. Hernandez et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
Klaus Krueger et al.
RHEUMATOLOGY INTERNATIONAL (2019)
HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis
Huji Xu et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2019)
Assessing Disease Activity in Psoriatic Arthritis: A Literature Review
Laura J. Tucker et al.
RHEUMATOLOGY AND THERAPY (2019)
Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries
Philip J. Mease et al.
RHEUMATOLOGY AND THERAPY (2019)
Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing Spondylitis
Linda E. Dean et al.
JOURNAL OF RHEUMATOLOGY (2018)
Quality of life in psoriatic arthritis
Tania Gudu et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Axial spondyloarthritis including ankylosing spondylitis
Juergen Braun
RHEUMATOLOGY (2018)
Comorbidities in spondyloarthritis including psoriatic arthritis
Anna Molto et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2018)
GOLIMUMAB IMPROVES WORK PRODUCTIVITY AND ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIASIS ARTHRITIS (PSA) AND AXIAL SPONDYLOARTHRITIS (AXSPA): INTERIM RESULTS FROM A NON-INTERVENTIONAL STUDY IN AUSTRIA (GO ACTIVE)
C. Dejacol et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Patient Burden of Axial Spondyloarthritis
Vibeke Strand et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2017)
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis
Florenzo Iannone et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients
Marco Garrido-Cumbrera et al.
RHEUMATOLOGY AND THERAPY (2017)
Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series study
Ji-chen Huang et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece
John N. Yfantopoulos et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2017)
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable
Roy M. Fleischmann et al.
RMD OPEN (2017)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
Monika M. Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis
Carmen Stolwijk et al.
ARTHRITIS CARE & RESEARCH (2016)
A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
J. Sieper et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis
Brigitte Michelsen et al.
PLOS ONE (2015)
The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
Desiree van der Heijde et al.
JOURNAL OF RHEUMATOLOGY (2014)
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
Fausto Salaffi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Arthur Kavanaugh et al.
ARTHRITIS CARE & RESEARCH (2013)
Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts
Majed Khraishi et al.
CLINICAL RHEUMATOLOGY (2011)
How to measure disease activity in axial spondyloarthritis?
Pedro Machado et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Quality of life and related variables in patients with ankylosing spondylitis
Hatice Bodur et al.
QUALITY OF LIFE RESEARCH (2011)
Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis
Janice A. Husted et al.
ARTHRITIS CARE & RESEARCH (2011)
Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis
Valerie P. Nell-Duxneuner et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Validity of the EuroQoL (EQ-5D) Instrument in a Greek General Population
Nick Kontodimopoulos et al.
VALUE IN HEALTH (2008)
Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study
R. De Angelis et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis
Annelies Boonen
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
HLA-B27-associated reactive arthritis: Pathogenetic and clinical considerations
I Colmegna et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis
SP McKenna et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
LC Doward et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)